GVHD organ involvement categories in the training cohort
Organ involvement . | First 24 categories . | Collapsed 14 categories . | Day 28 ORR (%) . | Glucksberg . | Minnesota risk . | CART . | K-means . | ||
---|---|---|---|---|---|---|---|---|---|
n . | 6-mo NRM (%) . | n . | 6-mo NRM (%) . | Manhattan risk . | Manhattan risk . | ||||
Isolated stage I skin | 135 | 5.3 | 135 | 5.3 | 63.0 | Grade 1 | Standard | Low | Low |
Isolated stage II skin | 259 | 7.8 | 259 | 7.8 | 76.1 | Grade 1 | Standard | Low | Low |
Isolated UGI | 112 | 8.1 | 112 | 8.1 | 73.2 | Grade 2 | Standard | Low | Low |
Stage I skin + UGI | 35 | 5.7 | 35 | 5.7 | 77.1 | Grade 2 | Standard | Low | Low |
Stage II skin + UGI | 33 | 21.2 | 33 | 21.2 | 81.8 | Grade 2 | Standard | Intermediate | Intermediate |
Stage I LGI ± UGI | 151 | 14.0 | 151 | 14.0 | 66.2 | Grade 2 | Standard | Intermediate | Intermediate |
Stage I skin + stage I LGI ± UGI | 47 | 14.9 | 83 | 14.6 | 71.1 | Grade 2 | Standard | Intermediate | Intermediate |
Stage II skin + stage I LGI ± UGI | 20 | 14.8 | Grade 2 | ||||||
Stage III skin + stage I LGI ± UGI | 16 | 12.5 | Grade 2 | ||||||
Stage III skin ± UGI | 222 | 11.8 | 222 | 11.8 | 72.5 | Grade 2 | Standard | Intermediate | Intermediate |
Stage II LGI ± UGI | 63 | 15.9 | 63 | 15.9 | 58.7 | Grade 3 | Standard | Intermediate | Intermediate |
Stage I liver ± other organ involvement | 20 | 35.5 | 59 | 46.6 | 40.7 | Grade 2-4 | Standard/High | High | High |
Stage II liver ± other organ involvement | 23 | 37.8 | Grade 3-4 | Standard/High | High | High | |||
Stage III liver ± other organ involvement | 12 | 73.1 | Grade 3-4 | Standard/High | High | High | |||
Stage IV liver ± other organ involvement | 4 | 75.0 | Grade 4 | Standard/High | High | High | |||
Stage I skin + stage II LGI ± UGI | 15 | 26.7 | 34 | 29.4 | 64.7 | Grade 3 | High | High | High |
Stage II skin + stage II LGI ± UGI | 10 | 40.0 | Grade 3 | ||||||
Stage III skin + stage II LGI ± UGI | 9 | 22.2 | Grade 3 | ||||||
Stage III LGI ± UGI | 53 | 34.3 | 53 | 34.3 | 43.4 | Grade 3 | High | High | High |
Stage I skin + stage III LGI ± UGI | 9 | 33.3 | 21 | 49.1 | 52.4 | Grade 3 | High | High | High |
Stage II skin + stage III LGI ± UGI | 7 | 65.7 | Grade 3 | ||||||
Stage III skin + stage III LGI ± UGI | 5 | 60.0 | Grade 3 | ||||||
Stage IV skin ± LGI ± UGI | 8 | 25.0 | 46 | 32.6 | 47.8 | Grade 4 | High | High | High |
Stage IV LGI ± skin ± UGI | 38 | 34.2 | Grade 3 |
Organ involvement . | First 24 categories . | Collapsed 14 categories . | Day 28 ORR (%) . | Glucksberg . | Minnesota risk . | CART . | K-means . | ||
---|---|---|---|---|---|---|---|---|---|
n . | 6-mo NRM (%) . | n . | 6-mo NRM (%) . | Manhattan risk . | Manhattan risk . | ||||
Isolated stage I skin | 135 | 5.3 | 135 | 5.3 | 63.0 | Grade 1 | Standard | Low | Low |
Isolated stage II skin | 259 | 7.8 | 259 | 7.8 | 76.1 | Grade 1 | Standard | Low | Low |
Isolated UGI | 112 | 8.1 | 112 | 8.1 | 73.2 | Grade 2 | Standard | Low | Low |
Stage I skin + UGI | 35 | 5.7 | 35 | 5.7 | 77.1 | Grade 2 | Standard | Low | Low |
Stage II skin + UGI | 33 | 21.2 | 33 | 21.2 | 81.8 | Grade 2 | Standard | Intermediate | Intermediate |
Stage I LGI ± UGI | 151 | 14.0 | 151 | 14.0 | 66.2 | Grade 2 | Standard | Intermediate | Intermediate |
Stage I skin + stage I LGI ± UGI | 47 | 14.9 | 83 | 14.6 | 71.1 | Grade 2 | Standard | Intermediate | Intermediate |
Stage II skin + stage I LGI ± UGI | 20 | 14.8 | Grade 2 | ||||||
Stage III skin + stage I LGI ± UGI | 16 | 12.5 | Grade 2 | ||||||
Stage III skin ± UGI | 222 | 11.8 | 222 | 11.8 | 72.5 | Grade 2 | Standard | Intermediate | Intermediate |
Stage II LGI ± UGI | 63 | 15.9 | 63 | 15.9 | 58.7 | Grade 3 | Standard | Intermediate | Intermediate |
Stage I liver ± other organ involvement | 20 | 35.5 | 59 | 46.6 | 40.7 | Grade 2-4 | Standard/High | High | High |
Stage II liver ± other organ involvement | 23 | 37.8 | Grade 3-4 | Standard/High | High | High | |||
Stage III liver ± other organ involvement | 12 | 73.1 | Grade 3-4 | Standard/High | High | High | |||
Stage IV liver ± other organ involvement | 4 | 75.0 | Grade 4 | Standard/High | High | High | |||
Stage I skin + stage II LGI ± UGI | 15 | 26.7 | 34 | 29.4 | 64.7 | Grade 3 | High | High | High |
Stage II skin + stage II LGI ± UGI | 10 | 40.0 | Grade 3 | ||||||
Stage III skin + stage II LGI ± UGI | 9 | 22.2 | Grade 3 | ||||||
Stage III LGI ± UGI | 53 | 34.3 | 53 | 34.3 | 43.4 | Grade 3 | High | High | High |
Stage I skin + stage III LGI ± UGI | 9 | 33.3 | 21 | 49.1 | 52.4 | Grade 3 | High | High | High |
Stage II skin + stage III LGI ± UGI | 7 | 65.7 | Grade 3 | ||||||
Stage III skin + stage III LGI ± UGI | 5 | 60.0 | Grade 3 | ||||||
Stage IV skin ± LGI ± UGI | 8 | 25.0 | 46 | 32.6 | 47.8 | Grade 4 | High | High | High |
Stage IV LGI ± skin ± UGI | 38 | 34.2 | Grade 3 |
UGI, upper gastrointestinal; LGI, lower gastrointestinal.